P01911 (DRB1_HUMAN) Homo sapiens (Human)
HLA class II histocompatibility antigen, DRB1 beta chain UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
108 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of HLA-DR15 with bound alpha3(135-145) peptide |
Heteromer P01903; | 50.0 | 1×NAG; 1×NAG; | |||
| Structure of HLA-DR1 with bound alpha3(135-145) peptide |
Heteromer P01903; | 50.0 | 1×NAG; | |||
| HLA-DR1 with CLIP102-120(M107W) |
Heteromer P01903; P04233; | 93.08 | ||||
| Structure of human MHC class II protein HLA-DR1 carrying an influenza hemagglutinin peptide partial… |
Heteromer P01903; | 93.23 | ||||
| Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation |
Heteromer P01903; P04233; | 92.94 | ||||
| COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB |
Heteromer P01552; P01903; | 93.23 | ||||
| CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC … |
Heteromer P01903; P02686; | 100 | 2×NAG; | |||
| Crystal structure of HLA-DRB1*04:01 with modified alpha-enolase peptide 326-340 (arginine 327 to ci… |
Heteromer P01903; P06733; | 91.05 | 3×MPD; 1×URE; 1×PGE; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified influenza A virus haemagg… |
Heteromer P01903; P03437; | 93.16 | 6×SO4; 16×EDO; | |||
| HLA-DR1 with the QAR Peptide |
Heteromer P01903; | 93.16 | 1×PEG; 4×EDO; 1×GOL; 1×SO4; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting influenza A virus haemagglutinin (HA)306-3… |
Heteromer P01903; P03437; | 93.16 | 1×EPE; 13×EDO; 8×GOL; | |||
| F11 TCR in complex with Human Leukocyte Antigen class II allotype DR1 presenting P11T->R modified i… |
Heteromer P01903; P03437; | 93.16 | 15×EDO; 2×P4G; | |||
| Crystal structure of HLA-DR1/TPI(23-37) complexed with staphylococcal enterotoxin C3 variant 3B2 (S… |
Heteromer P01903; P0A0L5; P60174; | 93.16 | ||||
| HLA class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope |
Heteromer P01903; Q13641; | 93.16 | 16×EDO; 3×PO4; | |||
| Crystal Structure of HLA-DR1 with CLIP102-120 |
Heteromer P01903; P04233; | 93.16 | 2×GOL; 1×FMT; | |||
| Crystal structure of HLA-DRB1*04:01 in complex with modified alpha-enolase peptide 26-40 with citru… |
Heteromer P01903; P06733; | 91.05 | ||||
| Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human MHC class II Molecu… |
Heteromer P01903; P04664; Q52T95; | 93.16 | 4×SO4; 1×EPE; 2×DIO; 1×ZN; | |||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB |
Heteromer P01552; P01903; | 90.61 | ||||
| Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1 |
Heteromer P01903; Q16655; | 93.16 | ||||
| Human class II MHC protein HLA-DR1 bound to a designed peptide related to influenza virus hemagglut… |
Heteromer P01903; P03437; P0A0L3; | 93.16 | ||||
| Crystal structure of CD4 mutant bound to HLA-DR1 |
Heteromer P01730; P01903; P03437; | 93.16 | 5×GOL; | |||
| HLA-DR1 complexed with a 13 residue HIV capsid peptide |
Heteromer P01903; P0A0L5; P12495; | 93.16 | ||||
| Crystal Structure of the MHC Class II Molecule HLA-DR1 in Complex with the Fluorogenic Peptide, AcP… |
Heteromer A8CDU0; P01903; P0A0L5; | 93.16 | ||||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the… |
Heteromer P01903; P0A0L5; | 93.05 | ||||
| Crystal structure of F24 TCR -DR11-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A5B9; P01903; P04585; | 91.58 | 2×NAG; 3×MG; | |||
| HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) |
Heteromer P01903; P27705; | 93.16 | ||||
| Crystal structure of HLA-DR1/TPI(23-37, Thr28-->Ile mutant) complexed with staphylococcal enterotox… |
Heteromer P01903; P0A0L5; P60174; | 93.05 | ||||
| Crystal structure of CD4 mutant bound to HLA-DR1 |
Heteromer P01730; P01903; P03437; | 92.97 | 1×GOL; | |||
| Crystal structure of a complete ternary complex between TCR, superantigen, and peptide-MHC class II… |
Heteromer A2NTY6; P01738; P01903; Q48898; | 92.94 | ||||
| HLA-DR1 complexed with a 16 residue HIV capsid peptide bound in a hairpin conformation |
Heteromer P01903; P0A0L5; P12495; | 93.16 | ||||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB |
Heteromer P01552; P01903; | 90.71 | ||||
| Crystal structure of F5 TCR -DR11-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A0G2JMB4; P01903; P04585; | 91.58 | 2×NAG; 4×SO4; 2×CL; 1×MG; | |||
| HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) and the superantigen SEC3-3B2 |
Heteromer P01903; P0A0L5; P27705; | 93.16 | ||||
| immune complex |
Heteromer P01308; P01903; | 90.66 | 1×NAG; 1×NAG; 3×MLI; | |||
| Crystal structure of HLA-DM bound to HLA-DR1 |
Heteromer P01903; P28067; P28068; | 92.82 | 1×NAG; | |||
| Crystal structure of HLA_DRB1*04:01 in complex with alpha-enolase peptide 26-40 |
Heteromer P01903; P06733; | 91.05 | ||||
| Crystal structure of the MAM-MHC complex |
Heteromer P01903; P11133; Q48898; | 93.16 | 2×PO4; | |||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the… |
Heteromer P01903; P0A0L5; | 93.05 | ||||
| HLA-DR1 with SGP Influenza Matrix Peptide |
Heteromer P01903; P05777; | 93.16 | 1×PEG; 4×EDO; 1×GOL; | |||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1(HA peptide 306-318) with the … |
Heteromer P01903; P0A0L5; | 93.05 | ||||
| HLA-DR1 bound with CLIP peptide |
Heteromer P01903; P04233; | 93.16 | ||||
| Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation |
Heteromer P01903; P04233; | 92.94 | ||||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01848; P01850; P01903; P60174; | 92.86 | ||||
| Mycoplasma arthritidis-derived mitogen complexed with class II MHC molecule HLA-DR1/HA complex in t… |
Heteromer P01903; Q48898; Q91LS8; | 93.16 | 2×PO4; | |||
| Crystal structure of an immune complex at pH 6.5 |
Heteromer P01903; P28067; P28068; | 92.9 | 3×NAG; | |||
| Crystal structure of F24 TCR -DR1-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A5B9; P01903; P04585; | 93.16 | 1×NAG; | |||
| HLA-DR1 with GMF Influenza PB1 Peptide |
Heteromer P01903; | 93.05 | ||||
| immune complex |
Heteromer P01308; P01903; | 90.66 | 1×NAG; | |||
| Crystal structure of HLA-DRB1*04:01 with the alpha-enolase peptide 326-340 |
Heteromer P01903; P06733; | 91.0 | 1×MRD; 2×URE; 2×MPD; | |||
| Immune Receptor |
Heteromer P01903; P08670; | 91.53 | 1×NAG; 2×NAG; 8×EDO; 1×PGE; | |||
| Immune Receptor |
Heteromer P01903; P08670; | 91.53 | 1×NAG; 2×NAG; 1×EDO; | |||
| Structure of F11TCR in complex with DR1 MHC Class II presenting PKYVKQNTLKLAT |
Heteromer P01903; P03435; | 93.12 | 6×EDO; 1×SO4; 2×PEG; | |||
| Immune Receptor |
Heteromer P01903; P16112; | 91.0 | 1×NAG; 2×NAG; 3×EDO; | |||
| Crystal structure of DR11 presenting the RQ13 peptide |
Heteromer P01903; P04585; | 91.53 | 1×NAG; 2×NAG; 8×SO4; 3×NA; | |||
| Immune Receptor |
Heteromer P01903; P08670; | 91.53 | 1×NAG; 2×NAG; 1×EDO; | |||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB |
Heteromer P01552; P01903; | 91.16 | 1×NAG; | |||
| HLA-DRB1 in complex with Histone 2B peptide |
Heteromer P01903; Q96A08; | 91.53 | 2×NAG; 1×B3P; | |||
| HLA-DRB1 in complex with citrullinated Histone 2B peptide |
Heteromer P01903; Q8N257; | 91.53 | 2×NAG; 1×B3P; | |||
| Crystal structure of Immune Receptor |
Heteromer P01903; P02458; | 91.0 | 3×NAG; 1×B3P; | |||
| HLA-DRB1 in complex with citrullinated fibrinogen peptide |
Heteromer P01903; P02675; | 91.0 | 2×NAG; | |||
| Immune Receptor |
Heteromer P01903; P08670; | 91.0 | 1×NAG; 2×NAG; | |||
| Structure of HLA-DR1 with a bound peptide with non-optimal alanine in the P1 pocket |
Heteromer P01903; P04439; | 93.12 | ||||
| HLA-DRB1 in complex with citrullinated LL37 peptide |
Heteromer P01903; P49913; | 91.53 | 2×NAG; | |||
| Immune Receptor |
Heteromer P01903; P08670; | 91.0 | 3×NAG; 2×EDO; | |||
| HLA-DRB1 in complex with citrullinated Vimentin peptide |
Heteromer P01903; P08670; | 90.32 | 2×NAG; | |||
| F54C HLA-DR1 bound with CLIP peptide |
Heteromer P01903; P04233; | 93.12 | ||||
| HLA-DR1 with covalently linked CLIP106-120 in canonical orientation |
Heteromer P01903; P04233; | 92.9 | 4×GOL; | |||
| Crystal structure of DR15 presenting the RQ13 peptide |
Heteromer P01903; P04585; | 99.47 | 2×NAG; 1×PGE; 1×PO4; | |||
| HLA-DRB1 in complex with citrullinated fibrinogen peptide |
Heteromer P01903; P02675; | 91.0 | 2×NAG; | |||
| Immune Receptor |
Heteromer P01903; P08670; | 91.0 | 3×NAG; | |||
| Crystal structure of DR11 presenting the gag293 epitope |
Heteromer P01903; P04585; | 91.53 | 1×NAG; 2×NAG; 5×SO4; 3×NA; 2×ACT; | |||
| X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II |
Heteromer P01552; P01903; P02458; | 90.39 | 1×NAG; | |||
| HLA-DRB1 in complex with Type II collagen peptide |
Heteromer P01903; P02458; | 91.0 | 1×NAG; 2×NAG; | |||
| T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 |
Heteromer P01903; P08670; | 90.61 | 2×NAG; 7×GOL; 6×SO4; 1×NAG; | |||
| Crystal structure of DR1 presenting the RQ13 peptide |
Heteromer P01903; P04585; | 92.86 | 2×PEG; 1×NAG; | |||
| Crystal structure of F24 TCR -DR15-RQ13 peptide complex |
Heteromer A0A0B4J272; A0A5B9; P01903; P04585; | 99.47 | 1×NAG; 2×MG; 1×SO4; | |||
| HLA-DRB1 in complex with citrullinated LL37 peptide |
Heteromer P01903; P49913; | 91.0 | 2×NAG; | |||
| X-ray structure of the complex between staphylococcal enterotoxin B, T cell receptor and major hist… |
Heteromer A0A5B9; P01552; P01848; P01903; P03437; | 93.12 | ||||
| HLA-DRB1*15:01 in complex with smith antigen |
Heteromer P01903; P63162; | 99.47 | 1×NAG; | |||
| HLA-DR1 with covalently linked CLIP106-120 in reversed orientation |
Heteromer P01903; P04233; | 92.82 | 2×GOL; | |||
| Crystal structure of the ternary complex between human T cell receptor, staphylococcal enterotoxin … |
Heteromer P01848; P01850; P01903; P0A0M0; Q03909; | 93.08 | 4×GOL; 1×NA; | |||
| Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide,… |
Heteromer P01848; P01850; P01903; P03437; | 91.11 | 1×NAG; 2×NAG; | |||
| T cell recognition of citrullinated alpha-enolase peptide presented by HLA-DR4 |
Heteromer P01903; P06733; | 90.29 | 1×NAG; 2×NAG; 2×ACT; 3×FMT; 2×GOL; | |||
| CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB |
Heteromer P01552; P01903; | 90.5 | ||||
| Crystal structure of HLA-DR4 bound to GP100 peptide |
Heteromer P01903; P40967; | 90.96 | ||||
| CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II |
Heteromer P01903; P0A0M0; Q03909; | 92.78 | 1×ZN; | |||
| CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE,… |
Heteromer P01848; P01850; P01903; P03437; | 92.74 | 2×NAG; | |||
| Structure of the Epstein-Barr Virus gp42 Protein Bound to the MHC class II Receptor HLA-DR1 |
Heteromer P01903; P03205; P03437; | 93.08 | ||||
| T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 |
Heteromer P01903; P08670; | 90.96 | 1×NAG; 10×GOL; | |||
| CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTI… |
Heteromer P01903; P04664; | 93.08 | 2×NAG; 4×NAG; | |||
| Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4 |
Heteromer A0A5B9; P01848; P01903; | 90.5 | ||||
| Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR |
Heteromer P01848; P01850; P01903; P60174; | 92.82 | ||||
| Crystal structure of the D227A variant of Staphylococcal enterotoxin A in complex with human MHC cl… |
Heteromer P01903; P0A0L2; | 93.08 | ||||
| Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4 |
Heteromer A0A5B9; P01730; P01848; P01903; | 90.5 | ||||
| Cryo-EM structure of human invariant chain in complex with HLA-DR15 |
Heteromer P01903; P04233; | 100 | ||||
| immune receptor complex |
Heteromer P01903; P02675; | 90.17 | 3×NAG; 20×GOL; 1×NA; | |||
| immune receptor complex |
Heteromer P01903; P02675; | 90.45 | 2×NAG; 13×GOL; | |||
| HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED… |
Heteromer P01903; P04439; | 93.05 | ||||
| immune receptor complex |
Heteromer P01903; P02675; | 90.45 | 1×NAG; 9×GOL; | |||
| Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T … |
Heteromer P01903; P60174; | 92.74 | 2×NA; | |||
| immune receptor complex |
Heteromer P01903; P02675; | 90.5 | 3×NAG; 4×GOL; | |||
| THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 |
Heteromer P01903; P04233; | 90.37 | 2×NAG; | |||
| immune receptor complex |
Heteromer P01903; P02675; | 90.56 | 3×NAG; 5×GOL; | |||
| immune receptor complex |
Heteromer P01903; P02675; | 90.56 | 3×NAG; 4×GOL; | |||
| HLA-DR1 mutant bN82A with covalently linked CLIP106-120(M107W) |
Heteromer P01903; | 92.18 | ||||
| TCR/HLA-DR2b/MBP-peptide complex |
Heteromer P01850; P01903; P02686; | 100.0 | 1×NAG; | |||
| TCR complex |
Heteromer P01903; | 100.0 | 2×NAG; 2×SO4; | |||
| Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101)… |
Heteromer P01903; P02458; | 85.48 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8vrw.1.B | monomer | 0.77 | 100.00 | |||